109 related articles for article (PubMed ID: 21506600)
1. 3-Trifluoromethylquinoxaline N,N'-dioxides as anti-trypanosomatid agents. Identification of optimal anti-T. cruzi agents and mechanism of action studies.
Benitez D; Cabrera M; Hernández P; Boiani L; Lavaggi ML; Di Maio R; Yaluff G; Serna E; Torres S; Ferreira ME; Vera de Bilbao N; Torres E; Pérez-Silanes S; Solano B; Moreno E; Aldana I; López de Ceráin A; Cerecetto H; González M; Monge A
J Med Chem; 2011 May; 54(10):3624-36. PubMed ID: 21506600
[TBL] [Abstract][Full Text] [Related]
2. Pyrimido[1,2-a]quinoxaline 6-oxide and phenazine 5,10-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi.
Lavaggi ML; Aguirre G; Boiani L; Orelli L; García B; Cerecetto H; González M
Eur J Med Chem; 2008 Aug; 43(8):1737-41. PubMed ID: 18068272
[TBL] [Abstract][Full Text] [Related]
3. 2H-benzimidazole 1,3-dioxide derivatives: a new family of water-soluble anti-trypanosomatid agents.
Boiani M; Boiani L; Denicola A; Torres de Ortiz S; Serna E; Vera de Bilbao N; Sanabria L; Yaluff G; Nakayama H; Rojas de Arias A; Vega C; Rolan M; Gómez-Barrio A; Cerecetto H; Gonzalez M
J Med Chem; 2006 Jun; 49(11):3215-24. PubMed ID: 16722639
[TBL] [Abstract][Full Text] [Related]
4. Improving anti-trypanosomal activity of 3-aminoquinoxaline-2-carbonitrile N1,N4-dioxide derivatives by complexation with vanadium.
Urquiola C; Vieites M; Aguirre G; Marín A; Solano B; Arrambide G; Noblía P; Lavaggi ML; Torre MH; González M; Monge A; Gambino D; Cerecetto H
Bioorg Med Chem; 2006 Aug; 14(16):5503-9. PubMed ID: 16709457
[TBL] [Abstract][Full Text] [Related]
5. Naftifine-analogues as anti-Trypanosoma cruzi agents.
Gerpe A; Boiani L; Hernández P; Sortino M; Zacchino S; González M; Cerecetto H
Eur J Med Chem; 2010 Jun; 45(6):2154-64. PubMed ID: 20163894
[TBL] [Abstract][Full Text] [Related]
6. Quinoxaline N,N'-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi. Structure-activity relationships.
Aguirre G; Cerecetto H; Di Maio R; González M; Alfaro ME; Jaso A; Zarranz B; Ortega MA; Aldana I; Monge-Vega A
Bioorg Med Chem Lett; 2004 Jul; 14(14):3835-9. PubMed ID: 15203172
[TBL] [Abstract][Full Text] [Related]
7. Trypanocidal properties, structure-activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives.
Estevez Y; Quiliano M; Burguete A; Cabanillas B; Zimic M; Málaga E; Verástegui M; Pérez-Silanes S; Aldana I; Monge A; Castillo D; Deharo E
Exp Parasitol; 2011 Apr; 127(4):745-51. PubMed ID: 21272583
[TBL] [Abstract][Full Text] [Related]
8. Mode of action of nifurtimox and N-oxide-containing heterocycles against Trypanosoma cruzi: is oxidative stress involved?
Boiani M; Piacenza L; Hernández P; Boiani L; Cerecetto H; González M; Denicola A
Biochem Pharmacol; 2010 Jun; 79(12):1736-45. PubMed ID: 20178775
[TBL] [Abstract][Full Text] [Related]
9. Anti-T. cruzi activities and QSAR studies of 3-arylquinoxaline-2-carbonitrile di-N-oxides.
Vicente E; Duchowicz PR; Benítez D; Castro EA; Cerecetto H; González M; Monge A
Bioorg Med Chem Lett; 2010 Aug; 20(16):4831-5. PubMed ID: 20634064
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates.
Romeiro NC; Aguirre G; Hernández P; González M; Cerecetto H; Aldana I; Pérez-Silanes S; Monge A; Barreiro EJ; Lima LM
Bioorg Med Chem; 2009 Jan; 17(2):641-52. PubMed ID: 19110434
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of new 2-arylcarbonyl-3-trifluoromethylquinoxaline 1,4-di-N-oxide derivatives and their reduced analogues.
Solano B; Junnotula V; Marín A; Villar R; Burguete A; Vicente E; Pérez-Silanes S; Aldana I; Monge A; Dutta S; Sarkar U; Gates KS
J Med Chem; 2007 Nov; 50(22):5485-92. PubMed ID: 17910426
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents.
Cogo J; Kaplum V; Sangi DP; Ueda-Nakamura T; Corrêa AG; Nakamura CV
Eur J Med Chem; 2015 Jan; 90():107-23. PubMed ID: 25461316
[TBL] [Abstract][Full Text] [Related]
13. Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: mechanism of action studies.
Boiani L; Aguirre G; González M; Cerecetto H; Chidichimo A; Cazzulo JJ; Bertinaria M; Guglielmo S
Bioorg Med Chem; 2008 Sep; 16(17):7900-7. PubMed ID: 18706821
[TBL] [Abstract][Full Text] [Related]
14. ESR, electrochemical, molecular modeling and biological evaluation of 4-substituted and 1,4-disubstituted 7-nitroquinoxalin-2-ones as potential anti-Trypanosoma cruzi agents.
Aguilera-Venegas B; Olea-Azar C; Norambuena E; Arán VJ; Mendizábal F; Lapier M; Maya JD; Kemmerling U; López-Muñoz R
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Mar; 78(3):1004-12. PubMed ID: 21239218
[TBL] [Abstract][Full Text] [Related]
15. Novel quinoxaline 1,4-di-N-oxide derivatives as new potential antichagasic agents.
Torres E; Moreno-Viguri E; Galiano S; Devarapally G; Crawford PW; Azqueta A; Arbillaga L; Varela J; Birriel E; Di Maio R; Cerecetto H; González M; Aldana I; Monge A; Pérez-Silanes S
Eur J Med Chem; 2013 Aug; 66():324-34. PubMed ID: 23811257
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.
Jaso A; Zarranz B; Aldana I; Monge A
J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of quinoxaline di-N-oxide derivatives with in vitro trypanocidal activity.
Pérez-Silanes S; Torres E; Arbillaga L; Varela J; Cerecetto H; González M; Azqueta A; Moreno-Viguri E
Bioorg Med Chem Lett; 2016 Feb; 26(3):903-906. PubMed ID: 26750255
[TBL] [Abstract][Full Text] [Related]
18. 1,2,5-Oxadiazole N-oxide derivatives and related compounds as potential antitrypanosomal drugs: structure-activity relationships.
Cerecetto H; Di Maio R; González M; Risso M; Saenz P; Seoane G; Denicola A; Peluffo G; Quijano C; Olea-Azar C
J Med Chem; 1999 Jun; 42(11):1941-50. PubMed ID: 10354402
[TBL] [Abstract][Full Text] [Related]
19. Anti-trypanosomatid benzofuroxans and deoxygenated analogues: synthesis using polymer-supported triphenylphosphine, biological evaluation and mechanism of action studies.
Castro D; Boiani L; Benitez D; Hernández P; Merlino A; Gil C; Olea-Azar C; González M; Cerecetto H; Porcal W
Eur J Med Chem; 2009 Dec; 44(12):5055-65. PubMed ID: 19837489
[TBL] [Abstract][Full Text] [Related]
20. Benzo[1,2-c]1,2,5-oxadiazole N-oxide derivatives as potential antitrypanosomal drugs. Part 3: Substituents-clustering methodology in the search for new active compounds.
Aguirre G; Boiani L; Cerecetto H; Di Maio R; González M; Porcal W; Denicola A; Möller M; Thomson L; Tórtora V
Bioorg Med Chem; 2005 Dec; 13(23):6324-35. PubMed ID: 16115774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
